id: NEW:medication_cost_barrier_to_sud_medication_treatment_rate_oud
name: Medication Cost Barrier for Alcohol Dependence Treatment â†’ SUD Medication Treatment Rate
from_node:
  node_id: NEW:medication_cost_barrier
  node_name: Medication Cost Barrier for Alcohol Dependence Treatment
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: SUD Medication Treatment Rate
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: High prices of alcohol dependence medications create financial barriers for patients seeking
  treatment'
- 'Step 2: Patients unable to afford medications may forego or discontinue pharmacotherapy'
- 'Step 3: Reduced medication uptake leads to lower overall utilization rates of evidence-based pharmacological
  treatments'
- 'Step 4: Lower treatment rates result in poorer outcomes for individuals with alcohol use disorder'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Roberta Agabio et al. 2021. "Use of Medications for the Treatment of Alcohol Dependence:
    A Retrospective Study Conducted in 2011-2012.." https://doi.org/10.2174/2589977512666201228121820'
  supporting_citations:
  - Additional citations require full-text access - abstract references 'previous studies conducted in
    other countries' showing lower medication use rates
  - Study references barriers documented in prior literature on AD medication underutilization
  - Comparison studies from other countries mentioned but not specifically cited in abstract
  doi: 10.2174/2589977512666201228121820
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: High medication costs serve as a structural barrier preventing patients with alcohol dependence
  from accessing pharmacotherapy, contributing to widespread underutilization of evidence-based treatments.
quantitative_effects:
  sample_size: 345
spatial_variation:
  varies_by_geography: true
  variation_notes: Study found higher medication use in Italy compared to other countries, attributed
    to free medication access
moderators:
- name: free_medication_access
  direction: strengthens
  strength: moderate
  description: When medications are provided free of charge, utilization rates increase substantially
    compared to settings where cost barriers exist
structural_competency:
  equity_implications: This mechanism identifies cost as a systemic barrier rather than blaming individuals
    for non-adherence. The study demonstrates that when structural barriers (cost) are removed, medication
    uptake improves, suggesting policy interventions around medication affordability could improve treatment
    rates.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.258047'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
